[
  {
    "ts": "2026-01-20T11:59:00+00:00",
    "headline": "Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa速 (Sotagliflozin) for the Treatment of Heart Failure",
    "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the launch of Inpefa速 (sotagliflozin) in the United Arab Emirates (UAE), the first country within the Viatris territories to commercialize the treatment. Future launches are planned in multiple countries over the next several years, supporting Viatris' strategy to expand access to the treatment in key markets outside of the U.S. and Europe.",
    "url": "https://finance.yahoo.com/news/viatris-expands-innovative-portfolio-cardiovascular-115900198.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "90caf4ed-dc4f-3ad3-ba51-c1c589123804",
      "content": {
        "id": "90caf4ed-dc4f-3ad3-ba51-c1c589123804",
        "contentType": "STORY",
        "title": "Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa速 (Sotagliflozin) for the Treatment of Heart Failure",
        "description": "",
        "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the launch of Inpefa速 (sotagliflozin) in the United Arab Emirates (UAE), the first country within the Viatris territories to commercialize the treatment. Future launches are planned in multiple countries over the next several years, supporting Viatris' strategy to expand access to the treatment in key markets outside of the U.S. and Europe.",
        "pubDate": "2026-01-20T11:59:00Z",
        "displayTime": "2026-01-20T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b",
          "originalWidth": 400,
          "originalHeight": 112,
          "caption": "Viatris OUS Logo (PRNewsfoto/Viatris Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q8X7v9Q2NGJ8HikeN5BEPA--~B/aD0xMTI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b.cf.webp",
              "width": 400,
              "height": 112,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g4h5fNpHKz3PzdbDqFxRYg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viatris-expands-innovative-portfolio-cardiovascular-115900198.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viatris-expands-innovative-portfolio-cardiovascular-115900198.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]